ABSCI CORP (ABSI) Fundamental Analysis & Valuation

NASDAQ:ABSI • US00091E1091

Current stock price

2.78 USD
-0.1 (-3.47%)
At close:
2.76 USD
-0.02 (-0.72%)
After Hours:

This ABSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ABSI Profitability Analysis

1.1 Basic Checks

  • In the past year ABSI has reported negative net income.
  • ABSI had a negative operating cash flow in the past year.
  • In the past 5 years ABSI always reported negative net income.
  • In the past 5 years ABSI always reported negative operating cash flow.
ABSI Yearly Net Income VS EBIT VS OCF VS FCFABSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -46.78%, ABSI perfoms like the industry average, outperforming 50.87% of the companies in the same industry.
  • With a decent Return On Equity value of -54.49%, ABSI is doing good in the industry, outperforming 62.24% of the companies in the same industry.
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROIC N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ABSI Yearly ROA, ROE, ROICABSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ABSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABSI Yearly Profit, Operating, Gross MarginsABSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ABSI Health Analysis

2.1 Basic Checks

  • ABSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ABSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ABSI Yearly Shares OutstandingABSI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ABSI Yearly Total Debt VS Total AssetsABSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 3.22 indicates that ABSI is not in any danger for bankruptcy at the moment.
  • ABSI has a Altman-Z score of 3.22. This is in the better half of the industry: ABSI outperforms 69.17% of its industry peers.
  • ABSI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ABSI (0.00) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.22
ROIC/WACCN/A
WACC9.37%
ABSI Yearly LT Debt VS Equity VS FCFABSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • ABSI has a Current Ratio of 5.89. This indicates that ABSI is financially healthy and has no problem in meeting its short term obligations.
  • ABSI's Current ratio of 5.89 is fine compared to the rest of the industry. ABSI outperforms 62.04% of its industry peers.
  • A Quick Ratio of 5.89 indicates that ABSI has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.89, ABSI is in the better half of the industry, outperforming 63.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.89
Quick Ratio 5.89
ABSI Yearly Current Assets VS Current LiabilitesABSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ABSI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.38% over the past year.
EPS 1Y (TTM)5.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.26%

3.2 Future

  • Based on estimates for the next years, ABSI will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.92% on average per year.
  • The Revenue is expected to grow by 81.93% on average over the next years. This is a very strong growth
EPS Next Y19.03%
EPS Next 2Y15.73%
EPS Next 3Y31.13%
EPS Next 5Y15.92%
Revenue Next Year313.07%
Revenue Next 2Y165.94%
Revenue Next 3Y158.87%
Revenue Next 5Y81.93%

3.3 Evolution

ABSI Yearly Revenue VS EstimatesABSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ABSI Yearly EPS VS EstimatesABSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. ABSI Valuation Analysis

4.1 Price/Earnings Ratio

  • ABSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ABSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABSI Price Earnings VS Forward Price EarningsABSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABSI Per share dataABSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ABSI's earnings are expected to grow with 31.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.73%
EPS Next 3Y31.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ABSI Dividend Analysis

5.1 Amount

  • No dividends for ABSI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ABSI Fundamentals: All Metrics, Ratios and Statistics

ABSCI CORP

NASDAQ:ABSI (3/27/2026, 8:00:00 PM)

After market: 2.76 -0.02 (-0.72%)

2.78

-0.1 (-3.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-24
Earnings (Next)05-11
Inst Owners77.6%
Inst Owner Change22.95%
Ins Owners6.31%
Ins Owner Change3.12%
Market Cap418.03M
Revenue(TTM)N/A
Net Income(TTM)-114.60M
Analysts81.33
Price Target8.21 (195.32%)
Short Float %29.56%
Short Ratio11.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.81%
Min EPS beat(2)-10.99%
Max EPS beat(2)7.37%
EPS beat(4)2
Avg EPS beat(4)1.03%
Min EPS beat(4)-10.99%
Max EPS beat(4)10.49%
EPS beat(8)2
Avg EPS beat(8)-2.82%
EPS beat(12)3
Avg EPS beat(12)-7.95%
EPS beat(16)3
Avg EPS beat(16)-8%
Revenue beat(2)0
Avg Revenue beat(2)-66.07%
Min Revenue beat(2)-77.45%
Max Revenue beat(2)-54.7%
Revenue beat(4)0
Avg Revenue beat(4)-51.89%
Min Revenue beat(4)-77.45%
Max Revenue beat(4)-12.08%
Revenue beat(8)0
Avg Revenue beat(8)-46.62%
Revenue beat(12)1
Avg Revenue beat(12)-43.85%
Revenue beat(16)2
Avg Revenue beat(16)-38.63%
PT rev (1m)0%
PT rev (3m)-0.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 148.5
P/FCF N/A
P/OCF N/A
P/B 1.99
P/tB 2.49
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.02
BVpS1.4
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.15%
Cap/Sales 43.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.89
Quick Ratio 5.89
Altman-Z 3.22
F-Score3
WACC9.37%
ROIC/WACCN/A
Cap/Depr(3y)44.41%
Cap/Depr(5y)179.67%
Cap/Sales(3y)101.78%
Cap/Sales(5y)229.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8%
EPS Next Y19.03%
EPS Next 2Y15.73%
EPS Next 3Y31.13%
EPS Next 5Y15.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.26%
Revenue Next Year313.07%
Revenue Next 2Y165.94%
Revenue Next 3Y158.87%
Revenue Next 5Y81.93%
EBIT growth 1Y-15.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.25%
EBIT Next 3Y-18.87%
EBIT Next 5Y-3.11%
FCF growth 1Y-17.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.2%
OCF growth 3YN/A
OCF growth 5YN/A

ABSCI CORP / ABSI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABSCI CORP (ABSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ABSI.


Can you provide the valuation status for ABSCI CORP?

ChartMill assigns a valuation rating of 1 / 10 to ABSCI CORP (ABSI). This can be considered as Overvalued.


How profitable is ABSCI CORP (ABSI) stock?

ABSCI CORP (ABSI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ABSI stock?

The Earnings per Share (EPS) of ABSCI CORP (ABSI) is expected to grow by 19.03% in the next year.